Publications
2025
Marotta G., Massenzio F., Ortega J., Russo D., Penna I., Falchi F., Babini G., Petralla S., Scarpelli R., Roggiolani E., Fricker G., Rosini M., Cavalli A., Monti B., Minarini A., Basagni F.
Exploration of the Neuromodulatory Properties of Fyn and GSK-3β Kinases Exploiting 7-Azaindole-Based Inhibitors
Journal of Medicinal Chemistry
Article
Journal
2025
Quatraccioni M., Ocello R., Falchi F., Previtali V., Veronesi M., Varignani G., Margaroli N., Masi M., Scarpelli R., Girotto S., Cavalli A.
In search of small molecules targeting RAD52 for synthetic lethality (P120)- September 14-17, 2025, Parma (Italy)
XXIX National Meeting on Medicinal Chemistry
Poster
Conference
2025
Codino A., Spagnoletti L., Olobardi C., Cuomo A., Santos-Rosa H., Palomba M., Margaroli N., Girotto S., Scarpelli R., Luan S.-L., Crocco E., Bianchini P., Bannister A.J., Gustincich S., Kouzarides T., Rizzo R., Barbieri I., Cremisi F., Vignali R., Pandolfini L.
METTL9 sustains vertebrate neural development primarily via non-catalytic functions
Nature Communications, vol. 16, (no. 1)
2025
Corno C., Russo D., Pignotti F., De Giorgi F., Penna I., Saccoliti F., Costantino M., Mirra L., Pettinari P., Carenini N., Corna E., Perta N., Ciniselli C.M., Pratesi P., Scarpelli R., Bertozzi F., Verderio P., Beretta G.L., Di Muccio G., Di Marino D., Bandiera T., Perego P.
Molecular targeting of the deubiquitinase USP14 to circumvent cisplatin resistance in ovarian carcinoma and identification of novel inhibitors
Cancer Drug Resistance, vol. 8, (no. 50)
Article
Journal
2025
Coco G., Annese V.F., Galli V., Penna I., Russo D., Veronesi M., Scarpelli R., Sabella S., Caironi M.
Printed Integrated Logic Circuits Based on Chitosan-Gated Organic Transistors for Future Edible Systems
Advanced Functional Materials
2025
Quatraccioni M., Ocello R., Falchi F., Previtali V., Veronesi M., Varignani G., Margaroli N., Masi M., Scarpelli R., Girotto S., Cavalli A.
Targeting RAD52 for synthetic lethality: discovery of a novel small molecule as a promising inhibitor for cancer therapy (P310)- August 31-September 4, 2025, Porto (Portugal)
X EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry
Poster
Conference
2024
Quaia R., Veronesi M., Anselmi M., Russo D., Penna I., Scarpelli R., Girotto S., Duca M., Bertozzi F., Bandiera T.
Developmental of fluorinated fragments into novel modulators of micro-RNA-21 levels
RNA Technologies Flagship, 2nd Annual Retreat, Genova
Poster
Conference
2024
Quaia R., Anselmi M., Russo D., Penna I., Veronesi M., Bertozzi F., Duca M., Bandiera T.
DEVELOPMENT OF NOVEL FRAGMENTS INTO MODULATORS OF MicroRNA-21 LEVELS
European School of Medicinal Chemistry
Poster
Conference
2024
Anselmi M., Russo D., Penna I., Quaia R., Bellina F., Panosetti M., Scarpelli R., Veronesi M., Girotto S., Bertozzi F., Duca M., and Bandiera T.
DRUG DISCOVERY PLATFORM FOR THE IDENTIFICATION OF microRNA-21 SMALL-MOLECULE MODULATORS IN PANCREATIC CELLS
RNA Technologies Flagship, 2nd Annual Retreat, Genova
Poster
Conference
2024
Bertozzi F., Mazzarella M. A., Bottegoni G., Ricci F., Russo D., Penna I., Reggiani A., Bandiera T.
Multitarget-directed Ligands for Multiple Sclerosis with combined Anti-inflammatory and Remyelinating properties (MARs)
Congresso Scientifico Annuale Associazione Italiana Sclerosi Multipla e la sua Fondazione
Poster
Conference
2023
Ugolini A., Vecchio D., Scarpelli R., Grimaldi B.
A new class of autophagy inhibitors for the treatment of cancer (P36)- September 10-13, 2023, Cambridge (United Kingdom)
XXII Medicinal Chemistry Symposium - SCI / RSC
Poster
Conference
2023
Demuro S., Di Martino R.M.C., Sauvey C., Tripathi S.K., Ortega J. A., Russo D., Penna I., Myers S. H., Bandiera T., Girotto S., Abagyan R., Cavalli A.
Design and synthesis of triple protein kinase inhibitors: paving the way towards novel CNS tools to reverse the aberrant tau phosphorylation
ACS Spring 2023 meeting
Poster
Conference
2023
Palomba M., Vecchio D., Allavena G., Capaccio V., De Mei C., Scarpelli R., Grimaldi B.
Identification of a Dual Autophagy and REV-ERB Inhibitor with in Vivo Anticancer Efficacy
Journal of Medicinal Chemistry
2023
Scarpelli R., Palomba M., Vecchio D., Ottonello G., Mandrup Bertozzi S., Summa M., Armirotti A., Bertorelli R., De Mei C., Grimaldi B.
Identification of a dual REV-ERBβ and autophagy inhibitor with in vivo anticancer efficacy (P222)- September 3-7, 2023, Zagreb (Croatia)
IX EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry
Poster
Conference
2023
Palomba M., Vecchio D., Allavena G., Capaccio V., De Mei C., Scarpelli R., Grimaldi B.
Lead optimization of a class of dual REV_ERB and autophagy inhibitors with in vivo anticancer efficacy (P45)- September 10-13, 2023, Cambridge (United Kingdom)
XXII Medicinal Chemistry Symposium - SCI / RSC
Poster
Conference